Related Experiment Videos
Cytotoxic cyclolignans from Koelreuteria henryi
Y N Song1, H L Zhang, C J Chang
1Department of Medicinal Chemistry and Pharmacognosy, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907.
Journal of Natural Products
|December 1, 1994
Summary
Researchers isolated three cyclolignans from Koelreuteria henryi, including a new compound, koelreuterin-1. These compounds were evaluated for their cytotoxicity and tubulin polymerization inhibitory activity.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacognosy
Background:
- Koelreuteria henryi is a plant species known for its potential medicinal properties.
- Cytotoxic compounds derived from natural sources are of significant interest for drug discovery.
Purpose of the Study:
- To isolate and characterize bioactive compounds from the cytotoxic fraction of Koelreuteria henryi.
- To evaluate the isolated cyclolignans for their cytotoxic and tubulin polymerization inhibitory activities.
Main Methods:
- Phytochemical investigation involving extraction and chromatographic separation.
- Structure elucidation using extensive 1H- and 13C-nuclear magnetic resonance (NMR) spectral analyses.
- Chemical transformations to confirm structural assignments.
Main Results:
- Isolation of three cyclolignans: a new compound, koelreuterin-1, and two known compounds, austrobailignan-1 and austrobailignan-2.
- Unambiguous structural confirmation of koelreuterin-1 through spectroscopic data and chemical conversions.
- Assessment of the cytotoxicity and tubulin polymerization inhibitory effects of the isolated compounds.
Conclusions:
- Koelreuteria henryi is a source of bioactive cyclolignans with potential therapeutic applications.
- Koelreuterin-1 represents a novel cyclolignan with potential as an anticancer agent.
- Further research is warranted to explore the pharmacological potential of these compounds.